Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
2020
DOI: 10.1016/j.biopha.2020.110129
|View full text |Cite
|
Sign up to set email alerts
|

SCUBE2, vascular endothelium, and vascular complications: A systematic review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0
1

Year Published

2021
2021
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(6 citation statements)
references
References 37 publications
0
5
0
1
Order By: Relevance
“…SCUBE2, as a member of the SCUBE family, is expressed in a wide range of human tissues including cardiovascular tissues. SCUBE2 is involved in vascular endothelial function changes and vascular complications, particularly in diabetes and atherosclerosis ( 45 ). The results of our study suggested that SCUBE2 might be a new target that played an important role in ICM.…”
Section: Discussionmentioning
confidence: 99%
“…SCUBE2, as a member of the SCUBE family, is expressed in a wide range of human tissues including cardiovascular tissues. SCUBE2 is involved in vascular endothelial function changes and vascular complications, particularly in diabetes and atherosclerosis ( 45 ). The results of our study suggested that SCUBE2 might be a new target that played an important role in ICM.…”
Section: Discussionmentioning
confidence: 99%
“…Recent advances in this area have also highlighted a shared mechanistic pathway involving inflammation and endothelium oxidation in endothelial dysfunction (212,213) . For instance, SNPs involved in processes related to endothelial and vascular health such as vascular endothelial growth factor receptor, platelet/endothelial cell adhesion molecule-, endothelial nitric oxide synthase and endothelin-1 contribute to local and systemic vascular disorders (214)(215)(216)(217)(218) , yet studies had small sample sizes, were limited in number or did not account for gene-environment interaction.…”
Section: The Link Between Risk Factors and Endothelial Dysfunction An Intermediary Marker Of Cvdmentioning
confidence: 99%
“…Поддержание микроциркуляции на достаточном уровне обеспечивается благодаря ингибированию адгезии и агрегации тромбоцитов, ограничению активации коагуляционных механизмов в каскадах взаимодействий тромбомодулин / протеин С, гепарин / антитромбин и плазминоген / плазмин и регуляции фибринолиза за счет синтеза t-PA и PAI-1 [39] Многочисленные патологические процессы, такие как атеросклероз, воспаление, кардиомиопатия, гипертония и т. д., сопровождаются формированием ЭДФ [16]. Окислительный стресс, воспаление, деградация и пролиферация гликокаликса при метаболических нарушениях являются факторами, которые ускоряют развитие ЭДФ [5]. Механизмы формирования ЭДФ, особенно при ПОУГ, начинаются с повреждения межклеточных контактов эндотелиоцитов и структуры гематоофтальмического барьера, что приводит к усилению адгезии лейкоцитов с экстравазацией, индукции прокоагулянтов и антифибринолитических систем [16].…”
Section: факторы развития и патогенез первичной открытоугольной глаукомыunclassified